Skip to Main Content
Yale School of Medicine
YSM Home

INFORMATION FOR

Catalina Mourgues-Codern

Associate Research Scientist in Psychiatry
DownloadHi-Res Photo

About

Titles

Associate Research Scientist in Psychiatry

Appointments

  • Psychiatry

    Associate Research Scientist
    Primary
    Psychiatry

Other Departments & Organizations

Education & Training

BA
Catholic University Chile (2008)

Research

Research at a Glance

Yale Co-Authors

Frequent collaborators of Catalina Mourgues-Codern's published research.

Publications

2026

2025

  • Instruments for assessing insight in psychosis: A systematic review of psychometric properties
    Hazan H, Tayfur S, Karmani S, Gibbs-Dean T, Mourgues C, Srihari V. Instruments for assessing insight in psychosis: A systematic review of psychometric properties. Psychological Medicine 2025, 55: e362. PMID: 41292267, PMCID: PMC12671917, DOI: 10.1017/s0033291725101918.
    Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
    This study investigates tools for assessing insight in psychosis, finding most scales reliable but highlighting the need for culturally adaptive, multidimensional measures for better clinical and research utility.
    Full Summary
  • Shift in sex and age of individuals at a clinical high risk (CHR) for psychosis: relation to differences in recruitment methods and effect on sample characteristics
    Farina E, Mourgues-Codern C, Stimler K, Kenney J, Saxena A, Mukhtar H, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Ellman L, Gold J, Keshavan M, Mathalon D, Mittal V, Perkins D, Schiffman J, Silverstein S, Strauss G, Stone W, Walker E, Waltz J, Corlett P, Powers A, Woods S. Shift in sex and age of individuals at a clinical high risk (CHR) for psychosis: relation to differences in recruitment methods and effect on sample characteristics. Schizophrenia 2025, 11: 123. PMID: 41053030, PMCID: PMC12501016, DOI: 10.1038/s41537-025-00663-5.
    Peer-Reviewed Original Research
  • Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program
    Addington J, Liu L, Braun A, Auther A, Calkins M, Cornblatt B, Corcoran C, Fusar-Poli P, Kerr M, Mourgues-Codern C, Nunez A, Oliver D, Strauss G, Walsh B, Alameda L, Arango C, Breitborde N, Broome M, Cadenhead K, Carrion R, Chen E, Choi J, Coleman M, Conus P, Diaz-Caneja C, Dwyer D, Ellman L, Faghankhani M, Gaspar P, Gerber C, Glenthøj L, Horton L, Hui C, Jacobs G, Kambeitz J, Kambeitz-Ilankovic L, Keshavan M, Kim S, Koutsouleris N, Kwon J, Langbein K, Lewandowski K, Mamah D, Marcy P, Mathalon D, Mittal V, Nordentoft M, Pearlson G, Penzel N, Perez J, Perkins D, Powers A, Rogers J, Sabb F, Schiffman J, Shah J, Silverstein S, Smesny S, Stone W, Thompson A, Thompson J, Upthegrove R, Verma S, Wang J, Wastler H, Wickham A, Rossum I, Wolf D, Bouix S, Pasternak O, Kahn R, Bearden C, Kane J, McGorry P, Buccilli K, Nelson B, Shenton M, Woods S, Yung A. Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program. Schizophrenia 2025, 11: 54. PMID: 40180953, PMCID: PMC11968923, DOI: 10.1038/s41537-025-00556-7.
    Peer-Reviewed Original Research
  • Emergence and Dynamics of Delusions and Hallucinations Across Stages in Early Psychosis
    Mourgues-Codern C, Benrimoh D, Gandhi J, Farina E, Vin R, Zamorano T, Parekh D, Malla A, Joober R, Lepage M, Iyer S, Addington J, Bearden C, Cadenhead K, Cornblatt B, Keshavan M, Stone W, Mathalon D, Perkins D, Walker E, Cannon T, Woods S, Shah J, Powers A. Emergence and Dynamics of Delusions and Hallucinations Across Stages in Early Psychosis. Biological Psychiatry 2025, 98: 679-688. PMID: 40020853, PMCID: PMC12353309, DOI: 10.1016/j.biopsych.2025.02.891.
    Peer-Reviewed Original Research
  • Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program
    Addington J, Liu L, Chu M, Jungert K, Penzel N, Pasternak O, Farina E, Carrion R, Corcoran C, Mittal V, Strauss G, Yung A, Alameda L, Arango C, Borders O, Bouix S, Breitborde N, Broome M, Cadenhead K, Castillo-Passi R, Chen E, Choi J, Coleman M, Conus P, Diaz-Caneja C, Ellman L, Poli P, Gaspar P, Gerber C, Glenthøj L, Horton L, Hui C, Kambeitz J, Kambeitz-Ilankovic L, Kapur T, Kelly S, Kerr M, Keshavan M, Kim M, Kim S, Koutsouleris N, Kwon J, Langbein K, Lewandowski K, Mamah D, Marcy P, Mathalon D, Mourgues C, Nordentoft M, Nunez A, Pearlson G, Perez J, Perkins D, Powers A, Rogers J, Sabb F, Schiffman J, Seitz-Holland J, Shah J, Silverstein S, Smesny S, Stone W, Thompson J, Upthegrove R, Verma S, Wang J, Wolf D, Zhang T, Addamo L, Buccilli K, Dwyer D, Todd S, Cho Y, Fontenau C, Tamayo Z, Bearden C, Kane J, McGorry P, Kahn R, Shenton M, Woods S, Barnaby A, Calkins M. Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program. Schizophrenia Bulletin Open 2025, 6: sgaf012. PMID: 40861307, PMCID: PMC12377803, DOI: 10.1093/schizbullopen/sgaf012.
    Peer-Reviewed Original Research
  • Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program
    Addington J, Shalev A, Liu L, Jahraus C, Chu M, Farina E, Poli P, Marcy P, Nunez A, Calkins M, Alameda L, Arango C, Borders O, Bouix S, Breitborde N, Broome M, Cadenhead K, Carrion R, Castillo-Passi R, Chen E, Choi J, Coleman M, Conus P, Corcoran C, Diaz-Caneja C, Ellman L, Gaspar P, Gerber C, Glenthøj L, Horton L, Hui C, Kambeitz J, Kambeitz-Ilankovic L, Kapur T, Kelly S, Kerr M, Keshavan M, Kim M, Kim S, Koutsouleris N, Kwon J, Langbein K, Lewandowski K, Mamah D, Mathalon D, Mittal V, Mourgues C, Nordentoft M, Pasternak O, Pearlson G, Penzel N, Perez J, Perkins D, Powers A, Rogers J, Sabb F, Schiffman J, Seitz-Holland J, Shah J, Silverstein S, Smesny S, Stone W, Strauss G, Thompson J, Upthegrove R, Verma S, Wang J, Wolf D, Yung A, Zhang T, Addamo L, Buccilli K, Todd S, Dwyer D, Bearden C, Kane J, McGorry P, Kahn R, Shenton M, Woods S, Barnaby A. Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program. Schizophrenia Bulletin Open 2025, 6: sgaf013. PMID: 40861306, PMCID: PMC12377801, DOI: 10.1093/schizbullopen/sgaf013.
    Peer-Reviewed Original Research

2024

See All Publications

Get In Touch

Contacts

Email